• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    Celgene Corporation (CELG)

    -NasdaqGS
    118.97 3.39(2.77%) Jan 28, 4:00PM EST
    |Pre-Market : 120.00 Up 1.03 (0.87%) 8:01AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:122.36
    Open:122.54
    Bid:119.00 x 200
    Ask:120.19 x 300
    1y Target Est:125.17
    Beta:2.02
    Next Earnings Date:29-Jan-15CELG Earnings announcement
    Day's Range:118.86 - 123.94
    52wk Range:66.85 - 124.60
    Volume:6,689,247
    Avg Vol (3m):5,153,100
    Market Cap:95.02B
    P/E (ttm):62.32
    EPS (ttm):1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGDown 2.77%95.02B
    JNJ284.05B

    Key Statistics

    Forward P/E (1 yr):24.43
    P/S (ttm):13.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.69
    Quarterly EPS Est (Dec-14) :0.99
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):1.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback